Category Archives: Coronary Heart Diseases

The researchers measured the visceral adipose tissue (VAT) and liver fat (LF) from magnetic resonance images of 12,276 participants from the UK Biobank, the researchers assessed and divided individuals into four groups defined by sex-specific median values of VAT and LF: low VAT-low LF, low VAT-high LF, high VAT-low LF, and high VAT-high LF. Participants were followed for 1.3 years (on average) to detect VAT-LF groups' associations with CHD incidence. In total, 176 CHD events were recorded, revealing that high visceral adiposity increased risk for CHD; this effect was exacerbated in those who also had low liver fat elevating the risk for CHD greater than two-fold compared with low VAT-low LF Continue reading →

Diabetes is a major risk factor for heart disease. Dr Santosh Kumar Dora, Senior Cardiologist, Asian Heart Institute, Mumbai, shares a few tips on how to avoid this risk. Apart from causing cholesterol deposits in the coronary arteries, diabetes also leads to higher incidence of hypertension and dyslipidemia Continue reading →

Coronary Artery disease (CAD) is a cardiovascular disorder which is caused by reduced flow or absent of blood flow in arteries that enclose and supply the heart which is commonly known as Ischemia. Usually in a coronary artery, due to deposition of fat, cholesterol, and calcium forms a thick layer in the wall of arteries which reduces the flow of blood. Coronary artery disease due to the limitation of blood flow the myocardial cell starts decreasing due to lack of oxygen Continue reading →

November 14 of each year marks the observation of World Diabetes Day, and this years theme is The Nurse and Diabetes. Continue reading →

Source: Getty Images November 18, 2020 -Racial health disparities have only gotten worse in the past twenty years, new data shows, despite Congressional and research efforts to better understand and mitigate disparities. The study, published in JAMA Network Open, showed that poor health indicators among Black patients have gotten worse since the turn of the new millennium. Continue reading →

Brilinta reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had an acute ischaemic stroke or transient ischaemic attack Subgroup analysis from the Phase III THALES trial showed treatment effect in easy-to-identify patient population Detailed results from a prespecified subgroup (n=2,351) analysis of the positive THALES Phase III trial showed AstraZenecas Brilinta (ticagrelor) 90mg used twice daily and taken with daily aspirin for 30 days reduced the rate of the composite of stroke and death by 27% (absolute risk reduction 3%, HR 0.73 [95% CI 0.56, 0.96], nominal p=0.023) compared to aspirin alone in patients who had an acute ischaemic stroke or a transient ischaemic attack (TIA) and had ipsilateral atherosclerotic stenosis in the head and neck (cervicocranial) arteries.1 This means that the number needed to treat (NNT) was 34 in this sub-group of patients compared to a NNT of 92 in the overall THALES population.1,2 This represents a consistent reduction in an easily identifiable patient population. In the subgroup of patients without ipsilateral stenosis at baseline, the rate of the primary composite endpoint of stroke or death was 4.8% for the aspirin and ticagrelor group versus 5.3% for the aspirin alone group (HR 0.89 [95% CI 0.74, 1.08]).1 Furthermore, aspirin plus ticagrelor also reduced the rate of the first secondary endpoint of ischaemic stroke by 28% (absolute risk reduction 2.9%, HR 0.72 [95 % CI 0.55, 0.95], nominal p=0.02) compared to aspirin alone up to day 30 in this sub-group.1 Atherosclerotic stroke or TIA can occur when a lipid-rich plaque ruptures in head and neck arteries leading to the formation of blood clots that may obstruct the blood flow to the brain. Continue reading →

Cardiovascular disorders or heart disorders are disorders of circulatory systems and heart. Inflammatory heart disease, hypertensive heart disease, cerebrovascular heart disease, rheumatic heart disease, and ischemic heart disease fall under the commonly diagnosed cardiovascular disorders. In most cases, the occurrence of high blood pressure leads to hypertensive heart ailments Continue reading →

Laith N AL-Eitan,1 Barakat Z Elsaqa,2 Ayah Y Almasri,1 Hatem A Aman,1 Rame H Khasawneh,3 Mansour A Alghamdi4,5 1Department of Biotechnology and Genetic Engineering, Faculty of Science and Arts, Jordan University of Science and Technology, Irbid 22110, Jordan; 2Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan; 3Department of Hematopathology, King Hussein Medical Center (KHMC), Royal Medical Services (RMS), Amman 11118, Jordan; 4Department of Anatomy, College of Medicine, King Khalid University, Abha 61421, Saudi Arabi; 5Genomics and Personalized Medicine Unit, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia Correspondence: Laith N AL-Eitan Department of Biotechnology and Genetic Engineering, Faculty of Science and Arts, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan Tel +962-2-7201000 ext 23464 Email lneitan@just.edu.jo Background: Cardiovascular disease is one of the most common causes of morbidity and mortality worldwide. Several cardiovascular diseases require therapy with warfarin, an anticoagulant with large interindividual variability resulting in dosing difficulties Continue reading →

To date, the magnitude of the threat of the coronavirus disease 2019 (COVID-19) on the human body is still unknown. Significant morbidity and mortalityare associated with the aging population, because of established cardiovascular disease and independent risk factors, suchas chronic lung disease, coronary artery disease, diabetes, hypertension, and malignancy. COVID-19 has been associatedwith direct and indirect cardiovascular complications, including acute myocardial injury, arrhythmias, myocarditis, and venous thromboembolism (VTE).1With the lack of concrete evidence on the impact of the virus full invasion on the human body, symptoms vary and present in different forms including ageusia and/or anosmia (~70%); confusion (9%); cough (68% to 83%); fatigue (23% to 38%); fever (44% to 98%); gastrointestinal symptoms, such as diarrhea, nausea, and vomiting (3% to 17%); muscle aches (11% to 15%); shortness of breath (11% to ~40%); and upper-respiratory symptoms, such as nasal or sinus congestion, rhinorrhea, and sore throat (5% to 61%).2Hence, the virus is exceedingly difficult to treat. Continue reading →

Market Report Summary For Full Information -> Click Here Read Full Press Release Below Growing prevalence of lethal diseases, such as cardiac arrest and heart failure due to changing lifestyle and eating habits is leading to increasing cardiac surgeries and procedures worldwide. Of late, intra-aortic balloon pump has emerged as a cutting-edge product in cardiac management and care. Continue reading →